These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. Cell- and peptide-based immunotherapeutic approaches for glioma. Yamanaka R Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264 [TBL] [Abstract][Full Text] [Related]
85. [Chemical modifiers in radiotherapy]. Nagashima T; Takakura K Gan No Rinsho; 1989 Sep; 35(11):1369-71. PubMed ID: 2681875 [TBL] [Abstract][Full Text] [Related]
86. [Antitumor effect of recombinant murine interferon-beta against mouse brain tumors]. Kuroki M Nihon Gan Chiryo Gakkai Shi; 1988 Mar; 23(3):771-80. PubMed ID: 3404024 [No Abstract] [Full Text] [Related]
87. [Efficacy of interferon-beta and interleukin-2 as cytokines for malignant brain tumor treatment]. Shitara N; Nakamura H; Genka S; Takakura K Gan To Kagaku Ryoho; 1987 Dec; 14(12):3235-44. PubMed ID: 3318704 [TBL] [Abstract][Full Text] [Related]
88. [Virally mediated immunotherapy as a component of combined treatment in malignant cerebral glioma]. Kartashev AV; Vinogradov VM; Pozdniakov AV; Kiseleva LN; Iagunov AS Vopr Onkol; 2010; 56(3):278-82. PubMed ID: 20804048 [No Abstract] [Full Text] [Related]
89. [Gene therapy for brain tumors: induction of apoptosis and immunogenic modulation in glioma cells (series 5)]. Asai A No Shinkei Geka; 1995 Jan; 23(1):7-15. PubMed ID: 7845524 [No Abstract] [Full Text] [Related]
90. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas. Lee Y; Bigner DD Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097 [TBL] [Abstract][Full Text] [Related]